cb8b01020_si_003.xlsx (121.15 kB)
Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors
dataset
posted on 2019-03-22, 00:00 authored by Maria Reinecke, Benjamin Ruprecht, Sandra Poser, Svenja Wiechmann, Mathias Wilhelm, Stephanie Heinzlmeir, Bernhard Kuster, Guillaume MédardChemical
proteomic approaches utilizing immobilized, broad-selective
kinase inhibitors (Kinobeads) have proven valuable for the elucidation
of a compound’s target profile under close-to-physiological
conditions and often revealed potentially synergistic or toxic off-targets.
Current Kinobeads enrich more than 300 native protein kinases from
cell line or tissue lysates but do not systematically cover phosphatidylinositol
3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related kinases
(PIKKs). Some PIKKs and PI3Ks show aberrant activation in many human
diseases and are indeed validated drug targets. Here, we report the
development of a novel version of Kinobeads that extends kinome coverage
to these proteins. This is achieved by inclusion of two affinity probes
derived from the clinical PI3K/MTOR inhibitors Omipalisib and BGT226.
We demonstrate the utility of the new affinity matrix by the profiling
of 13 clinical and preclinical PIKK/PI3K inhibitors. The large discrepancies
between the PI3K affinity values obtained and reported results from
recombinant assays led us to perform a phosphoproteomic experiment
showing that the chemoproteomic assay is the better approximation
of PI3K inhibitor action in cellulo. The results
further show that NVP-BEZ235 is not a PI3K inhibitor. Surprisingly,
the designated ATM inhibitor CP466722 was found to bind strongly to
ALK2, identifying a new chemotype for drug discovery to treat fibrodysplasia ossificans progressiva.
History
Usage metrics
Categories
Keywords
novel versiondrug targetsChemoproteomic Selectivity ProfilingCurrent KinobeadsATM inhibitor CP 466722PIKKdrug discoveryPI 3K inhibitors Omipalisibchemoproteomic assayALKPI 3K inhibitor actionkinome coveragecell linephosphatidylinositol 3- kinasesprotein kinasesaffinity matrixNVP-BEZ 235close-to-physiological conditionsphosphoproteomic experimentPI 3K inhibitorPI 3K Kinase Inhibitors Chemical proteomic approachesbroad-selective kinase inhibitorsBGT 226.PI 3K affinity valuesphosphatidylinositol 3- kinase-related kinasesPI 3Ks showaffinity probestissue lysatesPI 3Ksfibrodysplasia ossificans progressiva
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC